4.8 Article

Enhanced Gaussia Luciferase Blood Assay for Monitoring of in Vivo Biological Processes

Journal

ANALYTICAL CHEMISTRY
Volume 84, Issue 2, Pages 1189-1192

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ac202833r

Keywords

-

Funding

  1. NIH/NCI [4R00CA126839]
  2. NIH/NINDS [P30NS045776, 1R01NS064983]
  3. Fulbright scholarship
  4. Saal van Zwanenberg Foundation
  5. VSB fonds
  6. Dr. Hendrik Muller Vaderlandschfonds
  7. Dutch Cancer Foundation (KWF Kankerbestrijding)
  8. Hersenstichting brain fund
  9. Jo Keur (Leiden hospital)
  10. Huygens Scholarship Program
  11. Jo Keur

Ask authors/readers for more resources

Secreted Gaussia luciferase (Gluc) has been shown to be a useful tool for ex vivo monitoring of in vivo biological processes. The Gluc level in the blood was used to detect tumor growth, metastasis and response to therapy, gene transfer, and circulating cells viability, as well as transcription factors activation, complementing in vivo bioluminescence imaging. The sensitivity of the Gluc blood assay is limited due to the absorption of blue light by pigmented molecules such as hemoglobin, resulting in quenching of the signal and therefore lower sensitivity. To overcome this problem, we designed an alternative microtiter well-based binding assay in which Gluc is captured first from blood using a specific antibody followed by the addition of coelenterazine and signal acquisition using a luminometer. This assay showed to be over 1 order of magnitude more sensitive in detecting Gluc in the blood as compared to the direct Gluc blood assay enhancing ex vivo monitoring of biological processes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available